IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

25 hedge funds and large institutions have $12.8M invested in Insight Molecular Diagnostics Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 2 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
2
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$183K
2
NS
2
NBC Securities
Alabama
$1K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$38
4
Wells Fargo
4
Wells Fargo
California
$179

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$361K
2
PVI
2
Pura Vida Investments
New York
$1.54M
3
DC
3
Defender Capital
North Carolina
$164K
4
TRCT
4
Tower Research Capital (TRC)
New York
$5.51K
5
UBS Group
5
UBS Group
Switzerland
$2.53K
Name Market Value Shares Shares
Change 		Shares
Change %
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
– – -66 Closed
LC
27
Lindbrook Capital
California
– – -4 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2